Overall and Event-free Survival in Children with Acute Lymphoblastic Leukemia and Evaluation of Treatment Related Acute Toxicity

Özdoğan, Orhan; Ayçicek, Ali; Tekgündüz, Sibel Akpınar; Uysalol, Ezgi; Gökçe, Müge; Bayram, Cengiz

doi:10.4274/csmedj.galenos.2022.2022-1-4

csmedj

2022

DOI: 10.4274/csmedj.galenos.2022.2022-1-4

|View full text |Cite

Overall and Event-free Survival in Children with Acute Lymphoblastic Leukemia and Evaluation of Treatment Related Acute Toxicity

Orhan Özdoğan¹,

Ali Ayçicek²,

Sibel Akpınar Tekgündüz³

et al.

Abstract: Although childhood cancers can be treated with chemotherapy today, deaths and recurrences caused by the disease itself and the drugs used are seen at certain rates.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences

Cecconello,

Silva,

de Senna

et al. 2024

Pharmaceutics

View full text Add to dashboard Cite

Acute lymphoblastic leukemia represents the most prevalent childhood cancer. Modern chemotherapy has significantly improved outcomes, achieving EFS rates of 80% and OS rates nearing 90% in developed nations, while in developing regions, rates remain below 50%, highlighting disparities, and this difference is due to several factors. Genetic variability plays a role in these drug response disparities, presenting single-nucleotide variations (SNVs). Pharmacogenetic research aims to pinpoint these SNVs early in treatment to predict specific drug responses effectively. This review aims to explore advancements in pharmacogenetics associated with asparaginase (ASNase). ASNase plays a crucial role in the treatment of ALL and is available in three formulations: E. coli, Erwinia, and PEG ASNase. ASNase therapy presents challenges due to adverse effects, like hypersensitivity reactions. Identifying predictive markers for hypersensitivity development beforehand is crucial for optimizing treatments. Several pharmacogenetic studies have investigated the association between SNVs and the risk of hypersensitivity. Key genes include GRIA1, NFATC2, CNTO3, ARHGAP28, MYBBP1A, and HLA. Studies have highlighted associations between SNVs within these genes and hypersensitivity reactions. Notably, most pharmacogenetic investigations of hypersensitivity have focused on patients treated with E. coli, emphasizing the need for broader exploration across different formulations. Future research investigating these variants holds promise for advancing our understanding of ASNase’s pharmacogenetics.

show abstract

Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences

Cecconello,

Silva,

de Senna

et al. 2024

Pharmaceutics

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Overall and Event-free Survival in Children with Acute Lymphoblastic Leukemia and Evaluation of Treatment Related Acute Toxicity

Abstract: Although childhood cancers can be treated with chemotherapy today, deaths and recurrences caused by the disease itself and the drugs used are seen at certain rates.

Cited by 1 publication

References 47 publications

Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences

Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences

Contact Info

Product

Resources

About